Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Olavide Neuron STX S.L.
March 16, 2026
Olavide Neuron STX S.L.
Orphan Drug Designation
treatment of Huntington’s disease
Disease Area:
Rare Diseases
Source
Scroll to Top
